Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C11H12Cl2N2O |
Molecular Weight | 259.132 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H](OC1=C(Cl)C=CC=C1Cl)C2=NCCN2
InChI
InChIKey=KSMAGQUYOIHWFS-ZETCQYMHSA-N
InChI=1S/C11H12Cl2N2O/c1-7(11-14-5-6-15-11)16-10-8(12)3-2-4-9(10)13/h2-4,7H,5-6H2,1H3,(H,14,15)/t7-/m0/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/2879913
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2879913
Dexlofexidine is an isomer “+“ of lofexidine, which is agonist of alpha 2-adrenoceptor, but in 10 times less potent than the other isomer, levlofexidine.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2095158 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2879913 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
Interference of enantiomers of lofexidine with alpha-adrenoceptors. | 1985 Jan |
|
Two stereoisomeric imidazoline derivatives: synthesis and optical and alpha 2-adrenoceptor activities. | 1986 Jul |
|
Pharmacokinetics of lofexidine hydrochloride in healthy volunteers. | 2009 Jan |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2988468
in rats
Route of Administration:
Intravenous
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29709
Created by
admin on Fri Dec 15 16:07:53 GMT 2023 , Edited by admin on Fri Dec 15 16:07:53 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
208822
Created by
admin on Fri Dec 15 16:07:53 GMT 2023 , Edited by admin on Fri Dec 15 16:07:53 GMT 2023
|
PRIMARY | |||
|
81447-79-2
Created by
admin on Fri Dec 15 16:07:53 GMT 2023 , Edited by admin on Fri Dec 15 16:07:53 GMT 2023
|
PRIMARY | |||
|
VXJ7Z24RN1
Created by
admin on Fri Dec 15 16:07:53 GMT 2023 , Edited by admin on Fri Dec 15 16:07:53 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106205
Created by
admin on Fri Dec 15 16:07:53 GMT 2023 , Edited by admin on Fri Dec 15 16:07:53 GMT 2023
|
PRIMARY | |||
|
5256
Created by
admin on Fri Dec 15 16:07:53 GMT 2023 , Edited by admin on Fri Dec 15 16:07:53 GMT 2023
|
PRIMARY | |||
|
C77296
Created by
admin on Fri Dec 15 16:07:53 GMT 2023 , Edited by admin on Fri Dec 15 16:07:53 GMT 2023
|
PRIMARY | |||
|
100000083427
Created by
admin on Fri Dec 15 16:07:53 GMT 2023 , Edited by admin on Fri Dec 15 16:07:53 GMT 2023
|
PRIMARY | |||
|
DTXSID901024658
Created by
admin on Fri Dec 15 16:07:53 GMT 2023 , Edited by admin on Fri Dec 15 16:07:53 GMT 2023
|
PRIMARY | |||
|
SUB07035MIG
Created by
admin on Fri Dec 15 16:07:53 GMT 2023 , Edited by admin on Fri Dec 15 16:07:53 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)